Literature DB >> 15018171

Hemolysis, hemorrhage, headache, and hidden abortion: imaging findings in antiphospholipid syndrome.

Andreas H Mahnken1, Vincent M Brandenburg, Rolf D Frank, Patrick Haage, Rolf W Günther.   

Abstract

Antiphospholipid antibodies are associated with arterial and venous thromboses, recurrent pregnancy loss, and organ infarction. Any vascular region can be affected. We present a 20-year-old woman suffering from secondary antiphospholipid syndrome with a unique combination of multifocal venous thromboses, pulmonary embolism, spontaneous abortion, and splenic infarction. Diversity of clinical symptoms and diagnostic imaging modalities are discussed with emphasis on cross-sectional imaging. The syndrome should be suspected in patients with thromboses and organ infarctions of otherwise undetermined etiology.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15018171     DOI: 10.1007/s00330-003-1974-9

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  21 in total

Review 1.  The antiphospholipid syndrome.

Authors:  Jerrold S Levine; D Ware Branch; Joyce Rauch
Journal:  N Engl J Med       Date:  2002-03-07       Impact factor: 91.245

2.  Disseminated thrombosis in primary antiphospholipid syndrome: MR findings.

Authors:  J M Provenzale; C E Spritzer; R C Nelson; T L Ortel
Journal:  Eur J Radiol       Date:  1998-02       Impact factor: 3.528

3.  Antiphospholipid syndrome: patterns of life-threatening and severe recurrent vascular complications.

Authors:  E K Insko; Z J Haskal
Journal:  Radiology       Date:  1997-02       Impact factor: 11.105

Review 4.  Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance.

Authors:  P E Love; S A Santoro
Journal:  Ann Intern Med       Date:  1990-05-01       Impact factor: 25.391

5.  Pregnancy loss in the antiphospholipid-antibody syndrome--a possible thrombogenic mechanism.

Authors:  J H Rand; X X Wu; H A Andree; C J Lockwood; S Guller; J Scher; P C Harpel
Journal:  N Engl J Med       Date:  1997-07-17       Impact factor: 91.245

6.  MR-venography using high resolution True-FISP.

Authors:  E Spuentrup; A Buecker; M Stuber; R W Günther
Journal:  Rofo       Date:  2001-08

7.  The "primary" antiphospholipid syndrome: major clinical and serological features.

Authors:  R A Asherson; M A Khamashta; J Ordi-Ros; R H Derksen; S J Machin; J Barquinero; H H Outt; E N Harris; M Vilardell-Torres; G R Hughes
Journal:  Medicine (Baltimore)       Date:  1989-11       Impact factor: 1.889

8.  Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus.

Authors:  D Alarcón-Segovia; M E Pérez-Vázquez; A R Villa; C Drenkard; J Cabiedes
Journal:  Semin Arthritis Rheum       Date:  1992-04       Impact factor: 5.532

9.  Patients with antiphospholipid antibodies: CT and MR findings of the brain.

Authors:  J M Provenzale; D P Barboriak; N B Allen; T L Ortel
Journal:  AJR Am J Roentgenol       Date:  1996-12       Impact factor: 3.959

10.  Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus.

Authors:  R Cervera; M A Khamashta; J Font; G D Sebastiani; A Gil; P Lavilla; I Doménech; A O Aydintug; A Jedryka-Góral; E de Ramón
Journal:  Medicine (Baltimore)       Date:  1993-03       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.